Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthetic Biology

Givaudan inks ingredient deals with Ginkgo and Manus Bio

by Craig Bettenhausen
September 2, 2021 | A version of this story appeared in Volume 99, Issue 32

 

The flavor and fragrance firm Givaudan is delving deeper into synthetic biology through deals with Ginkgo Bioworks and Manus Bio. The firms aren’t sharing details, saying only that Ginkgo will aim to make “products such as those that are only available in minute quantities in nature” and that Manus will develop “natural and sustainable materials.” Both Ginkgo and Manus manipulate microorganisms to make custom small molecules, peptides, and proteins. Givaudan’s deal with Manus builds on a partnership that the firms say has yielded a food and beverage ingredient that will be available later this year.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.